Chemoimmunotherapy as long-term maintenance therapy for cancer

14Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Homeostatic immune regulatory mechanisms can mediate premature termination of therapy-induced antitumor T-effector cell responses. Administration of cyclophosphamide (CY) prior to intratumoral IL-12 and GM-CSF delivery blocked post-treatment T-suppressor cell rebound via elimination of the pre-existing T-suppressor cell pool, allowed repeated activation of antitumor cytotoxic T-cells and resulted in the cure of advanced spontaneous tumors. © 2012 Landes Bioscience.

Cite

CITATION STYLE

APA

Egilmez, N. K., Harden, J. L., & Rowswell-Turner, R. B. (2012). Chemoimmunotherapy as long-term maintenance therapy for cancer. OncoImmunology, 1(4), 563–565. https://doi.org/10.4161/onci.19369

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free